Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)

Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)

Introduction: The necessity for an equal distribution of the COVID-19 vaccination is critical. Lower-middle and lower income countries may not be able to manufacture their vaccines, nor may they be able to afford to buy them for every inhabitant. Furthermore, the vaccination's potency may wane...

Full description

Bibliographic Details
Main Authors: Nipon Chalermphanchai, Wachiraporn Arunothong, Niphawan Jettavan, Surin Chanta, Thunthiwa Boonpisitsakul, Monthon Mayoon, Piyawan Lueangchiranothai, Natthawat Yodsurang, Wichai Chanchue, Yupin Tananuchit, Kullaya Jangaroon, Waroonkarn Meungsuwan, Thantima Nantawong
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Vaccine: X
Subjects:
Antibody response after intradermal vaccination
Completed two-doses of Verocell (inactivated vaccine)
Safety
Tolerability
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136222000080

Internet

http://www.sciencedirect.com/science/article/pii/S2590136222000080

Similar Items